An official website of the United States government
NIH Guide: Weekly Index for March 22, 2024
Weekly NIH Guide Notices
March 22, 2024
Policy Notices
-
Guidance on Flexibilities for Conducting Semiannual Inspections of Animal Facilities
(NOT-OD-24-075)Office of the Director, NIH
-
Guidance on Flexibilities for Conducting Semiannual Program Review
(NOT-OD-24-076)Office of the Director, NIH
General Notices
-
Notice of Pre-Application Technical Assistance Webinar for RFA-DA-25-060
(NOT-DA-24-019)National Institute on Drug Abuse
-
Notice of NIBIB Participation in NOT-EY-23-009 "Notice of Special Interest (NOSI): Quantum Sensing in Biomedical Applications (SBIR/STTR)"
(NOT-EB-24-005)National Institute of Biomedical Imaging and Bioengineering
-
Notice of Informational Webinar for the National Institute of General Medical Sciences Medical Scientist Training Program (MSTP) (T32)
(NOT-GM-24-029)National Institute of General Medical Sciences
-
Notice of Information: NICHD to issue a Research Opportunity Announcement to support Advancing Cures and Therapies and ending ENDOmetriosis diagnostic delays - ACT ENDO (OTA Clinical Trial Optional)
(NOT-HD-24-016)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
NHLBI Announces New Policies Regarding Budget Guidelines for SBIR/STTR Applications
(NOT-HL-24-008)National Heart, Lung, and Blood Institute
-
Notice of Informational Webinar for PAR-23-144, STrengthening Research Opportunities for NIH Grants (STRONG): Structured Institutional Needs Assessment and Action Plan Development for Resource Limited Institutions (RLIs) (UC2 - Clinical Trial Not Allowed)
(NOT-MD-24-011)National Institute on Minority Health and Health DisparitiesNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
-
Notice to Rescind NOT-OD-21-080 "Updated Notice of Limited Availability of Research Non-Human Primates"
(NOT-OD-24-080)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
-
Registration Open for Webinar on NIH Simplified Review Framework for NIH Research Project Grants (RPGs): Implementation and Impact on Funding Opportunities
(NOT-OD-24-081)Office of the Director, NIH
-
Notice Announcing Publication of Development and Application of Ophthalmic Imaging Technologies to Advance Our Understanding of Systemic Diseases (OT2) Research Opportunity Announcement
(NOT-RM-24-007)Office of Strategic Coordination (Common Fund)
-
Notice Announcing the Systems Biology Data Platform Leveraging the Accelerating Medicines Partnership (OT2)
(NOT-RM-24-008)Office of Strategic Coordination (Common Fund)
-
Request for Information (RFI): Inviting Comments and Feedback on the National Institute of Diabetes and Digestive and Kidney Disease, Division of Kidney, Urologic, and Hematologic Diseases Institutional Network Award (U2C-TL1)
(NOT-DK-24-018)National Institute of Diabetes and Digestive and Kidney Diseases
Notice of Changes to Funding Opportunities
-
Notice of Change to Budget Information Listed in PAR-21-357, "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)"
(NOT-AG-23-085)National Institute on AgingNational Institute on Alcohol Abuse and AlcoholismNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Library of MedicineNational Institute of Mental HealthNational Institute on Minority Health and Health Disparities
-
Notice of Early Expiration of "Notice of Special Interest (NOSI): Investigations on Inborn Errors of Immunity/Primary Immunodeficiencies", NOT-AI-21-032
(NOT-AI-24-026)National Institute of Allergy and Infectious Diseases
-
Notice of Early Expiration of "Notice of Special Interest (NOSI): Molecular and Genetic Characterization of Inborn Errors of Immunity", NOT-AI-21-082
(NOT-AI-24-027)National Institute of Allergy and Infectious Diseases
-
Notice of Change to RFA-CA-22-045, NCI Outstanding Investigator Award (R35 Clinical Trial Optional)
(NOT-CA-24-038)National Cancer Institute
-
Notice of Change to Extend Application Due Dates for PAR-21-305 - Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
(NOT-DK-24-014)National Institute of Diabetes and Digestive and Kidney DiseasesNational Cancer InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentOffice of Disease Prevention
-
Notice of Change to Funding Opportunity: RFA-FD-24-030 Drug Development Tools Research Grants (U01) Clinical Trials Optional
(NOT-FD-24-006)Food and Drug Administration
-
Notice of Change to Funding Opportunity: RFA-FD-24-035 Development and Maintenance of the Animal Food Regulatory Program Standards (U19) Clinical Trial Not Allowed
(NOT-FD-24-007)Food and Drug Administration
-
Notice of Change to Funding Opportunity: RFA-FD-24-035 Development and Maintenance of the Animal Food Regulatory Program Standards (U19) Clinical Trial Not Allowed
(NOT-FD-24-008)Food and Drug Administration
-
Notice of Correction to Key Dates Listed in Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowships
(NOT-OD-24-082)Office of the Director, NIH
-
Notice of Change to the Instructions for Appendices in PAR-24-105 "Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)"
(NOT-OD-24-083)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
-
Termination of NOSI NOT-OD-22-192 - Administrative Supplements to NCATS CTSA Program KL2/K12 Institutional Career Development Awards as part of the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project
(NOT-TR-24-014)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Specialized Alcohol Research Centers (P50 Clinical trial Optional)
(NOT-AA-24-007)National Institute on Alcohol Abuse and Alcoholism
-
Notice of Intent to Publish a Funding Opportunity Announcement for Comprehensive Alcohol Research Centers (P60 Clinical trial Optional)
(NOT-AA-24-008)National Institute on Alcohol Abuse and Alcoholism
-
Notice of Intent to Publish a Funding Opportunity Announcement for REsearch Across Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers (U24 Clinical Trial Not Allowed)
(NOT-AT-24-037)National Center for Complementary and Integrative Health
-
Notice of Intent to Publish a Funding Opportunity Announcement for Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
(NOT-DK-24-017)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Intent to Publish a Funding Opportunity Announcement for Understanding the Intersection of Social Inequities to Optimize Health and Reduce Health Disparities: The Axes Initiative (R01 Clinical Trial Optional)
(NOT-NR-24-009)National Institute of Nursing ResearchNational Institute of Mental HealthOffice of Research on Women's Health
Notices of Special Interest
-
Notice of Special Interest (NOSI): Inborn Errors of Immunity/Primary Immunodeficiencies
(NOT-AI-24-024)National Institute of Allergy and Infectious Diseases
-
Notice of Special Interest (NOSI): Development of Imaging Techniques for High Resolution and Functional Scanning of In Vivo Human Sensory and Communication Systems
(NOT-DC-24-025)National Institute on Deafness and Other Communication Disorders
-
Notice of Special Interest (NOSI): Administrative Supplements to NCATS CTSA Program KL2/K12 Institutional Career Development Awards as part of the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project
(NOT-TR-24-015)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
Funding Opportunities
-
New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
(PAR-24-160)National Institute on AgingNational Cancer InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Biomedical Imaging and BioengineeringApplication Receipt Date(s): Multiple dates, see announcement.
-
New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
(PAR-24-161)National Institute on AgingNational Cancer InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): Multiple dates, see announcement.
-
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
(PAR-24-162)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): Multiple dates, see announcement.
-
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
(PAR-24-164)National Institute of Mental HealthApplication Receipt Date(s): Not Applicable
-
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
(PAR-24-165)National Institute of Mental HealthApplication Receipt Date(s): Not Applicable
-
Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed)
(RFA-AG-25-012)National Institute on AgingApplication Receipt Date(s): June 14, 2024
-
Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-AG-25-013)National Institute on AgingApplication Receipt Date(s): June 15, 2024
-
Tailoring HIV Curative Strategies to the Participant (UM1 Clinical Trial Not Allowed)
(RFA-AI-24-011)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): Multiple dates, see announcement.
-
Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data (R24 Clinical Trial Not Allowed)
(RFA-AT-24-007)National Center for Complementary and Integrative HealthOffice of Dietary SupplementsApplication Receipt Date(s): Multiple dates, see announcement.
-
Optimizing Health of Children and Adolescents with Perinatal HIV Exposure (U19 Clinical Trial Optional)
(RFA-HD-25-004)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute on Deafness and Other Communication DisordersNational Institute of Mental HealthApplication Receipt Date(s): Not Applicable
-
BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional)
(RFA-MH-25-110)National Institute of Mental HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Behavioral and Social Sciences ResearchApplication Receipt Date(s): Multiple dates, see announcement.
-
Lethal Means Safety Suicide Prevention Research in Healthcare and Community Settings (R34 Clinical Trial Required)
(RFA-MH-25-120)National Institute of Mental HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
(RFA-NS-24-016)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringApplication Receipt Date(s): Multiple dates, see announcement.
-
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
(RFA-NS-24-017)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringApplication Receipt Date(s): Multiple dates, see announcement.
-
BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)
(RFA-NS-24-031)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringApplication Receipt Date(s): Multiple dates, see announcement.
-
Mechanisms of Cognitive Fluctuations in ADRD Populations (R01 - Clinical Trial Optional)
(RFA-NS-25-014)National Institute of Neurological Disorders and StrokeNational Institute on AgingApplication Receipt Date(s): June 24, 2024
-
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
(RFA-RM-24-002)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): Multiple dates, see announcement.
-
NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
(RFA-RM-24-003)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): August 19, 2024
-
NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
(RFA-RM-24-004)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): September 03, 2024
-
NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
(RFA-RM-24-005)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): Multiple dates, see announcement.
-
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed)
(RFA-RM-24-007)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): July 26, 2024
NIH Guide Notices are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster